US Broker Ratings

Phathom Pharmaceuticals (PHAT): Exploring a 275% Potential Upside in Biotech Innovation

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stands at an intriguing intersection of innovation and opportunity within the biotechnology sector. With a market capitalization of $328.13 million, this U.S.-based biopharmaceutical company is..

Anbio Biotechnology (NNNN): Investor Outlook on a Rising Player in Medical Diagnostics

Anbio Biotechnology (NNNN), a German-based company specializing in in vitro diagnostics, is an emerging name in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. Despite its relatively..

Health Catalyst, Inc (HCAT): Analyst Ratings Signal Strong Potential with 88.72% Upside

Health Catalyst, Inc (HCAT), a key player in the healthcare information services sector, is capturing investor attention with an impressive potential upside of 88.72%. Headquartered in South Jordan, Utah, Health..

Grab Holdings Limited (GRAB) Stock Analysis: Strong Buy Ratings Signal 14.85% Potential Upside

Grab Holdings Limited (NASDAQ: GRAB), the Singapore-based technology giant, has positioned itself as a formidable player in the superapp ecosystem across Southeast Asia. With a market capitalization of $20.7 billion,..

Materialise NV (MTLS) Stock Analysis: Uncovering a 66.74% Upside Potential in the 3D Printing Sector

Materialise NV (NASDAQ: MTLS), a Belgium-based leader in the technology sector, is capturing attention on Wall Street with its intriguing growth potential. As an influential player in the software application..

Viant Technology Inc. (DSP): Investor Outlook With 57% Potential Upside and Strong Buy Ratings

Viant Technology Inc. (NASDAQ: DSP) is capturing investor attention with its robust potential for growth, as suggested by an enticing 57.38% upside based on current analyst target prices. Operating within..

Mereo BioPharma Group plc (MREO) Stock Analysis: Exploring a 198.94% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO), a promising player in the biotechnology sector, has recently caught the attention of investors with its substantial potential upside. With a market capitalization of..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Exploring the 66.98% Upside Potential for Investors

Nano-X Imaging Ltd (NASDAQ: NNOX) stands at the forefront of innovation in the medical devices sector, providing groundbreaking solutions in digital X-ray technology. The company, headquartered in Petah Tikva, Israel,..

WeRide Inc. (WRD) Stock Analysis: Unlocking a 94% Potential Upside in Autonomous Driving

WeRide Inc. (NASDAQ: WRD) is emerging as a noteworthy player in the autonomous driving sector, operating as both a robotaxi service and a provider of cutting-edge self-driving technologies. Based in..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Navigating a Challenging Market with 11.53% Upside Potential

Investors are closely watching ZoomInfo Technologies Inc. (NASDAQ: GTM) as the company navigates a fluctuating market environment. Despite recent challenges, the stock presents a potential upside of 11.53%, based on..

Aura Biosciences, Inc. (AURA) Stock Analysis: A 250% Potential Upside in the Biotechnology Sector

Investors seeking high-growth opportunities in the biotechnology sector might find Aura Biosciences, Inc. (NASDAQ: AURA) an intriguing prospect. With a market capitalization of approximately $380.71 million, this clinical-stage biotech company..

CS Disco, Inc. (LAW) Stock Analysis: Exploring a 41.83% Potential Upside Amidst Mixed Ratings

CS Disco, Inc. (NASDAQ: LAW), a promising player in the technology sector, is making waves in the software application industry with its innovative cloud-native and AI-powered legal products. Headquartered in..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Unpacking a 125% Upside Potential

A2Z Cust2Mate Solutions Corp. (AZ), a burgeoning player in the technology sector, has captured the attention of investors with its ambitious foray into the retail smart cart solutions market. As..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a 260% Upside Potential in Biotech Innovation

For investors with an eye on the biotechnology sector, aTyr Pharma, Inc. (NASDAQ: ATYR) represents a compelling opportunity. With a current market capitalization of $457.48 million, this clinical-stage biotech company..

CytomX Therapeutics, Inc. (CTMX): A Biotech Stock with a Potential 119% Upside

CytomX Therapeutics, Inc. (CTMX), a biopharmaceutical company based in South San Francisco, California, is capturing investor attention with its innovative approach to oncology treatments. The company specializes in developing conditionally..

Nyxoah SA (NYXH) Stock Analysis: A 68.7% Potential Upside Sparks Investor Interest

Nyxoah SA (NASDAQ: NYXH), a Belgium-based healthcare innovator in the medical instruments and supplies industry, is capturing investor attention with its significant potential upside of 68.7%. Specializing in solutions for..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Exploring a Potential 504% Upside in Biotech Innovation

Gossamer Bio, Inc. (NASDAQ: GOSS) is catching the eye of investors with an enticing potential upside of over 500% according to recent analyst ratings. Operating in the dynamic biotechnology sector,..

Nerdy Inc. (NRDY) Stock Analysis: Exploring the 23.55% Potential Upside for Investors

Nerdy Inc. (NRDY), a key player in the technology sector under the software application industry, presents an intriguing opportunity for investors looking to capitalize on its current market dynamics. With..

Sanara MedTech Inc. (SMTI) Stock Analysis: Exploring a 67% Upside Potential in the Healthcare Sector

Sanara MedTech Inc. (NASDAQ: SMTI) is emerging as a compelling opportunity within the healthcare sector, particularly in the niche of medical instruments and supplies. With a market capitalization of approximately..

ServiceTitan, Inc. (TTAN) Stock Analysis: A High-Growth Play with 7.27% Potential Upside

ServiceTitan, Inc. (TTAN) has carved out a prominent niche in the technology sector, primarily focusing on providing end-to-end, cloud-based software solutions tailored for a wide array of service industries. From..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds